The Valley Desk

ArticleJournal of medicinal chemistryPublished

Discovery and In Vivo Evaluation of Aryl Ether YAP1/TEAD Inhibitors for the Treatment of Hippo-Driven Malignancies

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source

Institution
Merck & Co.

Publication record

Type
Article
Venue
Journal of medicinal chemistry
Published
Subject terms
Animals; Humans; Mesothelioma; Sulfonamides; Transcription Factors; Antineoplastic Agents; Xenograft Model Antitumor Assays; Structure-Activity Relationship; Drug Discovery; Hippo Signaling Pathway; YAP-Signaling Proteins
PubMed ID
41678808
Added to directory
Source checked

Report a correction or request removal